Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia

Liver International

Volumn 30, Issue 8, 2010, Pages 1152-1160

  Utama, Andi ^a   Tania, Navessa Padma ^a   Dhenni, Rama ^a   Gani, Rino Alvani ^b   Hasan, Irsan ^b   Sanityoso, Andri ^b   Lelosutan, Syafruddin A R ^c   Martamala, Ruswhandi ^c   Lesmana, Laurentius Adrianus ^b   Sulaiman, Ali ^d   Tai, Susan ^a  

^a Mochtar Riady Institute for Nanotechnology   (Indonesia)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c Gatot Soebroto Hospital   (Indonesia)

^d Klinik Hati 'Prof Ali Sulaiman'   (Indonesia)

Author keywords

Core region; Genotype; Hepatitis C virus; Indonesia; Liver disease

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INDONESIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS; VIRUS CORE; VIRUS LOAD; VIRUS STRAIN;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CLUSTER ANALYSIS; DNA PRIMERS; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INDONESIA; LIVER CIRRHOSIS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STATISTICS, NONPARAMETRIC; VIRAL CORE PROTEINS; VIRAL LOAD;

EID: 79951657218     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02280.x     Document Type: Article

References (39)

1. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-73.
2. Simmonds P, Smith DB, McOmish F, et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994; 75: 1053-61.
3. Utama A, Budiarto BR, Monasari D, et al. Hepatitis C virus genotype in blood donors and associated liver disease in Indonesia. Intervirology 2008; 51: 410-6.
4. Hotta H, Handajani R, Lusida MI, et al. Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5B region sequences. J Clin Microbiol 1994; 32: 3049-51.
5. Soetjipto, Handajani R, Lusida MI, et al. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J Clin Microbiol 1996; 34: 2875-80.
6. Inoue Y, Sulaiman HA, Matsubayashi K, et al. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg 2000; 62: 92-8.
7. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-65.
8. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
9. Myers RP, Patel K, Pianko S, et al. The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. J Viral Hepat 2003; 10: 16-22.
10. Hadziyannis SJ, Sette H Jr, Morgan TR, et al. Peginterferonalpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55.
11. Jeffers LJ, Cassidy W, Howell CD, et al. Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology 2004; 39: 1702-8.
12. Akuta N, Suzuki F, Sezaki H, et al. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 2005; 48: 372-80.
13. Akuta N, Suzuki F, Sezaki H, et al. Predictive factors of virological nonresponse to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. JMed Virol 2006; 78: 83-90.
14. Akuta N, Suzuki F, Kawamura Y, et al. Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia. Intervirology 2007; 50: 361-8.
15. Akuta N, Suzuki F, Kawamura Y, et al. Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 2007; 46: 403-10.
16. Akuta N, Suzuki F, Kawamura Y, et al. Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b. J Med Virol 2007; 79: 1686-95.
17. Mori N, Imamura M, Kawakami Y, et al. Randomized trial of high-dose Interferon-a-2b combined with Ribavirin in patients with chronic hepatitis C: correlation between amino acid substitutions in the Core/NS5A region and virological response to interferon therapy. J Med Virol 2009; 81: 640-9.
18. Akuta N, Suzuki F, Kawamura Y, et al. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 2007; 46: 1357-64.
19. Akuta N, Suzuki F, HirakawaM, et al. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus. J MedVirol 2009; 81: 1032-9.
20. Tachi Y, Katano Y, Honda T, et al. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region in liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C. Liver Int 2010; 30: 554-9.
21. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-25.
22. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences.J Mol Evol 1980; 16: 111-20.
23. Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.. Mol Biol Evol 2007; 24: 1596-9.
24. Hraber PT, Fischer W, Bruno WJ, et al. Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: the 50 untranslated region (UTR) fails to classify subtypes. Virol J 2006; 3: 103.
25. Cantaloube JF, Laperche S, Gallian P, et al. Analysis of the 50 noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 2006; 44: 2051-6.
26. Mellor J, Walsh EA, Prescott LE, et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 1996; 34: 417-23.
27. Ohno O, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 201-7.
28. Lole KS, Jha JA, Shrotri SP, et al. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol 2003; 41: 5240-4.
29. Chinchai T, Labout J, Noppornpanth S, et al. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 2003; 109: 195-201.
30. Donlin MJ, Cannon NA, Yao E, et al. Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy. J Virol 2007; 81: 8211-24.
31. Okanoue T, Itoh Y, Minami M, et al. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts. Hepatol Res 2008; 38: 27-36.
32. Kalinina O, Norder H, Mukomolov S, et al. A natural intergenotypic of hepatitis C virus identified in St. Petersburg. J Virol 2002; 76: 4034-43.
33. Colina R, Casane D, Vasquez S, et al. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 2004; 85: 31-7.
34. Kageyama S, Agdamag DM, Alesna ET, et al. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006; 78: 1423-8.
35. Noppornpanth S, Lien TX, Poovorawan Y, et al. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006; 80: 7569-77.
36. Moreau I, Hegarty S, Levis J, et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C virus in Ireland. Virol J 2006; 3: 95.
37. Legrand-Abravanel F, Claudinon J, Nicot F, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 2007; 81: 4357-62.
38. Kurbanov F, Tanaka Y, Avazova D, et al. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 2008; 38: 457-64.
39. Lee YM, Lin HJ, Chen YJ, et al. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J Med Virol 2010; 82: 57-68.